Synthetic mRNA capping

Scholarly Works

• Szebeni, J. Unique Features and Collateral Immune Effects of mRNA-LNP COVID-19 Vaccines: Plausible Mechanisms of Adverse Events and Complications. Pharmaceutics 2025, 17, 1327. doi:10.3390/pharmaceutics17101327
• Kim, H.-J.; Le, N. D.; Oh, H.-J.; Kim, B.; Yoo, E.; Kim, J.; Yim, H. Lipid nanoparticle-assisted mRNA therapy for cancer treatment. Applied Physics Reviews 2025, 12. doi:10.1063/5.0247029
• Oh, K.; Choi, Y.; Hong, S. Patent landscape and innovation trajectories of mRNA vaccine technologies. World Patent Information 2025, 82, 102382. doi:10.1016/j.wpi.2025.102382
• Yamamoto, T.; Yoshida, T.; Uchida, Y.; Ohoka, N.; Yamashita, T.; Uchida, E.; Inoue, T. Analytical factors for optimization of chain-length distribution analysis of mRNA using capillary gel electrophoresis. Journal of chromatography. A 2025, 1754, 466019. doi:10.1016/j.chroma.2025.466019
• Zhang, W.; Wang, C.; Meng, Y.; He, L.; Dong, M. EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma. Vaccines 2025, 13, 478. doi:10.3390/vaccines13050478
• Wang, T.; Qin, B. R.; Li, S.; Wang, Z.; Li, X.; Jiang, Y.; Qin, C.; Ouyang, Q.; Lou, C.; Qian, L. Discovery of diverse and high-quality mRNA capping enzymes through a language model-enabled platform. Science advances 2025, 11, eadt0402. doi:10.1126/sciadv.adt0402
• Heiser, B. J.; Veyssi, A.; Ghosh, D. Recent strategies for enhanced delivery of mRNA to the lungs. Nanomedicine (London, England) 2025, 20, 1043–1069. doi:10.1080/17435889.2025.2485669
• Wei, Z.; Zhang, S.; Wang, X.; Xue, Y.; Dang, S.; Zhai, J. Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects. Frontiers in immunology 2025, 16, 1524317. doi:10.3389/fimmu.2025.1524317
• Khorshid Sokhangouy, S.; Behzadi, M.; Rezaei, S.; Farjami, M.; Haghshenas, M.; Sefidbakht, Y.; Mozaffari-Jovin, S. mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing-Insights From COVID-19 as a Model for Combating Infectious Diseases. Biotechnology journal 2025, 20, e202400596. doi:10.1002/biot.202400596
• Solodushko, V.; Kim, J. H.; Fouty, B. A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection. Gene therapy 2025, 32, 349–358. doi:10.1038/s41434-025-00521-0
• Aitbaev, K. A.; Murkamilov, I. T.; Fomin, V. V.; Yusupova, T. F.; Yusupova, Z. F.; Yusupov, F. A.; Hakimov, S. S.; Ymankulov, D. S.; Kudaibergenova, I. O. mRNA-therapy: problems and prospects of application in nephrology. Nephrology (Saint-Petersburg) 2025, 28, 30–38. doi:10.36485/1561-6274-2024-28-4-30-38
• Fu, Q.; Zhao, X.; Hu, J.; Jiao, Y.; Yan, Y.; Pan, X.; Wang, X.; Jiao, F. mRNA vaccines in the context of cancer treatment: from concept to application. Journal of translational medicine 2025, 23, 12. doi:10.1186/s12967-024-06033-6
• Shariati, A.; Khani, P.; Nasri, F.; Afkhami, H.; Khezrpour, A.; Kamrani, S.; Shariati, F.; Alavimanesh, S.; Modarressi, M. H. mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy. Biomarker research 2024, 12, 157. doi:10.1186/s40364-024-00692-9
• Sun, N.; Su, Z.; Zheng, X. Research progress of mosquito-borne virus mRNA vaccines. Molecular therapy. Methods & clinical development 2024, 33, 101398. doi:10.1016/j.omtm.2024.101398
• Abe, H.; Kimura, Y.; Honma, M.; Nakamoto, K.; Motosawa, K.; Atago, T.; Asano, K.; Hashiya, F.; Abe, N.; Kobayashi, K.; Ogisu, R.; Hashimoto, A.; Hiraishi, K.; Saito, S.; Yamamoto, J.; Iwai, H. Position-Specific Nucleoside Sugar Modifications in mRNA ORF: Enhancing Translational Function through Complete Chemical Synthesis of mRNA. Springer Science and Business Media LLC 2024. doi:10.21203/rs.3.rs-4312265/v1
• Drążkowska, K.; Tomecki, R.; Tudek, A. Purification of Enzymatically Active Xrn1 for Removal of Non-capped mRNAs from In Vitro Transcription Reactions and Evaluation of mRNA Decapping Status In Vivo. Methods in molecular biology (Clifton, N.J.) 2024, 2863, 81–105. doi:10.1007/978-1-0716-4176-7_7
• Ripp, A.; Krämer, M.; Barth, V.; Moser, P.; Haas, T. M.; Singh, J.; Huck, T.; Gleue, L.; Friedland, K.; Helm, M.; Jessen, H. J. The P(III)‐Amidite Based Synthesis of Stable Isotope Labeled mRNA‐Cap‐Structures Enables their Sensitive Quantitation from Brain Tissue. Angewandte Chemie 2024, 137. doi:10.1002/ange.202414537
• Ripp, A.; Krämer, M.; Barth, V.; Moser, P.; Haas, T. M.; Singh, J.; Huck, T.; Gleue, L.; Friedland, K.; Helm, M.; Jessen, H. J. The P(III)-Amidite Based Synthesis of Stable Isotope Labeled mRNA-Cap-Structures Enables their Sensitive Quantitation from Brain Tissue. Angewandte Chemie (International ed. in English) 2024, 64, e202414537. doi:10.1002/anie.202414537
• Kumar, D.; Singh, A.; Kaviraj, S.; Singh, S. Unveiling Fundamentals and Research Opportunities of mRNA Technology. Biotechnology in India - Reworking A Strategy; Springer Nature Singapore, 2024; pp 113–146. doi:10.1007/978-981-97-0896-3_5
• Karimi-Sani, I.; Molavi, Z.; Naderi, S.; Mirmajidi, S.-H.; Zare, I.; Naeimzadeh, Y.; Mansouri, A.; Tajbakhsh, A.; Savardashtaki, A.; Sahebkar, A. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials. Journal of nanobiotechnology 2024, 22, 601. doi:10.1186/s12951-024-02882-x

Explore citations to this article at